CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Carter Charles Ross Chief Financial Officer | Grant or award | +50,000 | 94,375 | ||
| 2026-06-15 | Greka Anna Director | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2026-04-07 | Fitzgerald Kevin Joseph Director | Grant or award | +17,578 | $2.56 | $45K | 17,578 |
| 2026-04-07 | Friedman Bart Director | Grant or award | +8,789 | $2.56 | $22K | 8,789 |
| 2026-04-07 | PAPADOPOULOS STELIOS Director | Grant or award | +17,578 | $2.56 | $45K | 217,578 |
| 2026-03-23 | LEVIN JEREMY M Executive Chairman | Option exercise | +47,333 | $1.40 | $66K | 3,735,048 |
| 2026-03-23 | LEVIN JEREMY M Executive Chairman | Option exercise · Series A Warrant (right to buy) | −47,333 | 0 | ||
| 2026-02-26 | ALEXANDER MARGARET A. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,435,000 | 1,435,000 | ||
| 2026-02-26 | Fitzgerald Kevin Joseph Director | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-02-26 | Bernstein Karen Director | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-02-26 | Friedman Bart Director | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-02-26 | DUNCAN BARBARA GAYLE Director | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-02-26 | Rona Jeffrey A CBFO | Grant or award | +68,125 | 156,313 | ||
| 2026-02-26 | Rona Jeffrey A CBFO | Grant or award · Employee Stock Option (Right to Buy) | +408,750 | 408,750 | ||
| 2026-02-26 | LEVIN JEREMY M Director | Grant or award · Employee Stock Option (Right to Buy) | +957,000 | 957,000 | ||
| 2026-02-26 | PAPADOPOULOS STELIOS Director | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-02-23 | ALEXANDER MARGARET A. President and CEO | Sale | −11,656 | $1.45 | $17K | 61,750 |
| 2026-02-23 | Rona Jeffrey A CBFO | Sale | −8,541 | $1.45 | $12K | 88,188 |
| 2026-01-04 | ALEXANDER MARGARET A. President and CEO | Grant or award · Employee Stock Option (right to buy) | +890,000 | 890,000 | ||
| 2025-12-15 | LEVIN JEREMY M CEO | Conversion | +71,000 | 3,687,715 |
Page 1 of 7 · 123 trades